COM

VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE

PAC (qualified). Lobbyist or registrant PAC.

PAC (qualified)Lobbyist or registrant PACMixed activity · 54% Democratic / 45% Republican · 1% unclassifiedInferred from activityMonthly filer

Financial snapshot

FEC bulk summary totals through Dec 31, 2024

Total receipts$320K

FEC reported disbursements$238.4KReported total may include noncash accounting entries

Individual contributions$319K

FEC reported cash on hand$202K

Coverage Not reported to Dec 31, 2024Contribution refunds $0Debts owed by committee $0Last report Not reported

Candidate connections

Candidate identity and documented relationships · 2023–2024

Candidate campaign receiving transfers
AGUILAR, PETEDemocraticFEC reported
U.S. House · California · District 33
Election 2024 · Incumbent · Current candidate
Receiving campaign: PETE AGUILAR FOR CONGRESS
Candidate details & sources
FEC candidate ID: H2CA31125 · 2023–2024 reporting cycle
Candidate campaign receiving transfers
BALDERSON, WILLIAM TROY

Registration details

Locally ingested FEC master-file snapshot for 2023–2024

Committee type: PAC (qualified)
Designation: Lobbyist or registrant PAC
Party affiliation: No party affiliation reported
Treasurer: VENTIMIGLIA, SAMANTHA
Filing cadence: Monthly filer
Organization type: Corporation
Connected organization: Not reported
Cycles loaded: 2026, 2024
Registered address: 1050 K STREET, NW · SUITE 1125 · WASHINGTON, DC, 20001

Political alignment

Registration, linked-candidate, and disclosed money-flow evidence

Evidence-based classificationMixed activity · 54% Democratic / 45% Republican · 1% unclassifiedMixed activity · 54% Democratic / 45% Republican · 1% unclassifiedInferred from activity

FEC registration: PAC (qualified); no party affiliation reported. Classification basis: Inferred from activity. This describes disclosed financial activity, not an official party registration or ideological score. The figures below separately preserve the filer’s Schedule E support and opposition designations.

No candidate support/oppose spending foundThis cycle has no locally ingested Schedule E rows for this committee. Registration, linked-candidate, committee-transfer, and recipient-reported conduit evidence can still establish the alignment shown above.

$0 supporting · $0 opposing · 0 rowsOfficial FEC outside spending ↗

Source & provenance

Trace this profile back to the public record

Source agencyFederal Election Commission

Local row ingestedSep 4, 2026

Source row hashccfd3eececcb656692e873ff8d0b3ded9630ffe1a564381b7bf4b1974fc3811d

View official FEC record

Financial figures are processed FEC totals and may change when amended reports are filed. Registration fields preserve raw master-file values loaded for the 2023–2024 snapshot.

Contributor	Reported context	Date	Election	Amount	FEC record
LEIDEN, JEFFREY`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsBOSTON MA 02210	EXECUTIVE CHAIRMAN VERTEX PHARMACEUTICALS INCORPORATEDM3	Feb 21, 2024	Primary (P)	$5,000	Original filing ↗
KEARNEY, TERRENCE`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsBOSTON MA 02210	BOARD MEMBER VERTEX PHARMACEUTICALS INCORPORATEDM2	Jan 10, 2024	Primary (P)	$5,000	Original filing ↗
THORNBERRY, NANCY`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsBOSTON MA 02210	BOARD MEMBER VERTEX PHARMACEUTICALS, INC.YE	Dec 27, 2024	Primary (P)	$5,000	Original filing ↗
SCHNEIDER, JENNIFER`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsSAINT HELENA CA 94574	BOARD MEMBER VERTEX PHARMACEUTICALS INCORPORATEDYE	Dec 27, 2024	Primary (P)	$5,000	Original filing ↗
SACHDEV, AMIT`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsWASHINGTON DC 20001	EVP, CHIEF PATIENT AND EXTERNAL AFFAIR VERTEX PHARMACEUTICALS INCORPORATEDYE	Dec 19, 2024	Primary (P)	$5,000	Original filing ↗
MCKENZIE, DIANA`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsWILMINGTON NC 28411	BOARD MEMBER VERTEX PHARMACEUTICALS, INC.YE	Dec 27, 2024	Primary (P)	$5,000	Original filing ↗
CARNEY, LLOYD`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsBOSTON MA 02210	BOARD MEMBER VERTEX PHARMACEUTICALS INCORPORATEDYE	Dec 5, 2024	Primary (P)	$5,000	Original filing ↗
THORNBERRY, NANCY`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsBOSTON MA 02210	BOARD MEMBER VERTEX PHARMACEUTICALS, INC.YE	Dec 30, 2023	Primary (P)	$5,000	Original filing ↗
SACHDEV, AMIT`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsWASHINGTON DC 20001	EVP, CHIEF PATIENT AND EXTERNAL AFFAIR VERTEX PHARMACEUTICALS INCORPORATEDYE	Oct 18, 2023	Primary (P)	$5,000	Original filing ↗
MCKENZIE, DIANA`View reported donor profile →`Supports 54% Democratic / 45% Republican · 1% unclassifiedDerived from contributionsWILMINGTON NC 28411	BOARD MEMBER VERTEX PHARMACEUTICALS, INC.YE	Dec 27, 2023	Primary (P)	$5,000	Original filing ↗

Recipient	Purpose	Date	Amount	FEC record
CASSIDY LEADERSHIP FUND`C00771543`BATON ROUGE, LA	24KMY 24KLinked: C00771543	Jun 16, 2023	$5,000	FEC disbursement search ↗
DENALI LEADERSHIP PAC`C00438291`ALEXANDRIA, VA	24KM10 24KLinked: C00438291	Sep 9, 2024	$5,000	FEC disbursement search ↗
MONTANANS FOR TESTER`C00412304`HELENA, MT	24KYE 24KLinked: C00412304	Dec 7, 2023	$5,000	FEC disbursement search ↗

VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE

Financial snapshot

Candidate connections

Registration details

Political alignment

Source & provenance

FEC-reported relationships

Money network

Cash, assets & liabilities

Receipts

Contribution breakdowns

Largest itemized receipts

Disbursements

Largest disbursements

Loans, debts & allocations

Reports & filings